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Abstract The TSH receptor (TSHR) and the LHKG receptor 
(LHR) are members of the family of G protein-coupled receptors. 
Recently, point mutations conferring constitutive activity to the 
TSHR and LHR have been observed as a cause of toxic adenoma 
and familial/sporadic male pseudo-precocious puberty, respec- 
tively. When evaluated by transfection in COS-7 cells the wild- 
type (wt) TSHR displays definite constitutive activity towards 
Gs-dependent adenylylcyclase stimulation, while available evi- 
dence shows that the LHR does not. In order to compare the 
constitutive activity of both receptors, we performed functional 
studies in COS-7 cells using different assay conditions. Human 
TSHR and LHR cDNAs subcloned in the expression vector 
pSVL were transiently expressed in COS-7 cells and CAMP 
production was determined following incubation in a medium 
containing physiological concentration of NaCl [isotonic (NaCI)] 
or in the same medium without NaCl [bypotonic (NaCl-)I or 
where NaCl was replaced by an isoosmolar concentration of 
sucrose [isotonic (sucrose)]. Cells transfected with the TSHR 
showed higher basal CAMP levels over cells transfected with 
pSVL in all conditions tested. The effect was stronger when cells 
were incubated in isotonic (sucrose) buffer. Cells expressing LHR 
exhibited a minimal increase of CAMP levels over cells trans- 
fected with pSVL in isotonic (NaCl) buffer; however, a marked 
increase in basal CAMP levels was observed when cells were 
assayed in hypotonic (NaCIf) or isotonic (sucrose) buffers. Vary- 
ing the pH or incubation temperature was without effect on the 
results obtained with both receptors. Our data show that despite 
extensive sequence similarity, the LH and TSH receptors differ 
markedly in their basal activity. The differential sensitivity of 
both receptors to low NaCl concentrations, suggests that the 
unliganded TSH receptor is less constrained than its LH homolog 
and may be more susceptible to activation by a wide spectrum of 
mutations. 
Key word.~; Thyrotropin receptor; LuteinizingKhorionic 
gonadotropin receptor; G protein-coupled receptor; 
Constitutive activity; CAMP; NaCi-free medium 
1. Introduction 
The TSH receptor (TSHR) and LH/CG receptor (LHR) to- 
gether with the FSH receptor are members of a subfamily of 
G protein-coupled receptors (GPCR) [l-3]. These receptors 
share a similar structural pattern with seven transmembrane 
segments connected by three extra and intracellular loops, a 
short cytoplasmic tail and a long extracellular domains that has 
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been shown to encode the specificity for hormone recognition 
and binding [1,2,4]. Both the TSH and LH receptors have the 
potential to activate the CAMP as well as inositolphoshate-Ca” 
cascades through activation of two independent G proteins, 
Gs-a and Gq-a, respectively [447]. Recently, somatic and 
germline mutations of the TSHR gene causing toxic adenoma 
or toxic thyroid hyperplasia. respectively, have been identified 
[8-121. These mutations cause increased agonist-independent 
production of CAMP (all cases) [8-121 and inositolphosphates 
(some somatic mutations) [12] when evaluated by transient 
expression in COS-7 cells. Similar activating mutations affect- 
ing LHR have been described as a cause of familial and spo- 
radic male pseudoprecocious puberty [ 13,141. Interestingly, 
when tested in COS-7 cells, the wt TSHR has been shown to 
activate CAMP production in the absence of agonist i.e. it 
displays also some constitutive activity [S-l 1.15,16]. On the 
contrary, available evidence suggests that when transiently ex- 
pressed in COS-7 cells the LHR, unlike TSHR, does not show 
any constitutive activity [I 31. 
The present study was conducted to explore in greater detail 
the different behaviour of the two receptors. Our results con- 
firm that the unliganded TSHR exhibits definite constitutive 
activity under conditions where the LHR is virtually silent. 
They demonstrate that removal of NaCl from the medium 
bathing COS-7 cells transfected with the cDNA constructs, 
unmasks strong constitutive activity of the LHR, while still 
increasing the basal activity of the TSHR. 
2. Materials and methods 
2. I. Constructs 
The plasmid pSVL containing the human TSHR and mouse melano- 
cortin receptor (MCSR) cDNAs have been previously described 117,181. 
The cDNA of the human LHR in the pudvector was a kind gift from 
Professor T. Minegishi (Gunma University,Japan) The cDNA was sub- 
cloned in pBluescript SK(+). A XhoI restriction site followed bv a 
consensus sequence-(GGAAAA) was introduced just before the first 
ATG by PCR with the following primers: forward primer: S-GCCT- 
CGAGGGAAAAATGAAGCAGCGGTCTCGGCGG-3’ reverse 
primer: 5’-CCATCTCAAGCTTTCAGAGG-3’ 
After removing most of the 3’ non-translated region, subcloning in 
the pSVL expression vector was performed. The sequence was con- 
firmed by double-strand sequencing with Sequenase‘ Kit (version 2; 
USB, Cleveland, OH) according to the manufacturer’s instructions. 
2.2. Trunsient expression of TSH and LHICG receptors cDNAs 
COS-7 cells were propagated in Dulbecco’s modified Eagle’s medium 
containing 10% fetal bovine serum at 37°C in an atmosphere containing 
5% CO>. The cells were plated at a density of 150,000 cells/dish (3 cm 
diameter). 24 h later, cells were transfected with the diethylaminoethyl- 
dextran method followed by a 2-min 10% dimethylsulfoxide shock after 
3 h. Differences in the efficiency of transfection and cell survival, were 
responsible for the different absolute CAMP levels observed in different 
experiments. 
All rights reserved. 
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2.3. Functional assay 
Cells were used 48 h after transfection for CAMP determination. 
Triplicate dishes were used for each condition and each experiment was 
repeated at least 3x; all assays always included control cells transfected 
with pSVL vector alone. 
Results are expressed as mean?S.E. When not shown. S.E. values are 
so small that they fall within the symbols. 
2.4. Measurement of’ cAMP accumulation 
Experiments were performed in Krebs-Ringer-HEPES buffer (KRH) 
[isotonic (NaCl)], KRH where the NaCl was replaced with 280 mM 
sucrose [isotonic (sucrose)] and KRH without NaCl [hypotonic 
(NaCIF)]. The culture medium was removed, cells were rinsed once with 
1 ml of the appropriate buffer and preincubated for 30 min in 1 ml of 
the same buffer. Thereafter, cells were incubated for 60 min in fresh 
buffer supplemented with 25 PM of the phosphodiesterase inhibitor 
Rohpram (kindly provided by laboratories Jacques Logeais, Troppes, 
France) and the agonists under study. At the end of incubation. the 
medium was collected, 1 ml HCl 0.1 M was added and the samples were 
dried in a vacuum concentrator (Savant). Extracellular (using the hypo- 
tonic (NaCI-) buffer) and intracellular (using both isotonic buffers) 
CAMP were measured in the medium or in cell extract, respectively, 
with a commercial radioimmunoassay Kit (Amersham, code 432, TRK) 
and expressed as pmol/dish. We choose to measure extracellular CAMP 
under hypotonic conditions, because >90% of the total CAMP was 
released in the medium in this condition In some experiments using the 
isotonic (NaCI) buffer, the effect on CAMP accumulation of varying the 
pH of the buffer (6.5-g) or the temperature of incubation (2842°C) 
was assessed. 
3. Results 
3.1. Constitutive activity. 
3.1.1. Basal cAMP measurement Basal CAMP levels were 
measured in extracts from COS-7 cells transfected with increas- 
ing amounts of TSHR or LHR DNA constructs. Whether they 
were measured after incubation in isotonic (NaCl) or isotonic 
(sucrose) buffers, CAMP levels reached a plateau at 100 ngldish 
of DNA transfected for both receptors (Fig. lA,B). The ab- 
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sence of a consensus regarding the specific bioactivity of pure 
bovine TSH (reported values vary by a factor of 5-IO-fold [19]) 
makes it impossible to compare rigorously the level of expres- 
sion achieved for the two receptors in molar terms. Neverthe- 
less, binding experiments with ‘?-labeled TSH and hCG were 
performed with COS-7 cells transfected with saturating 
amounts of the two constructs: similar level of expression were 
obtained (250,000450,000 receptors/cell) when using the high- 
est (more likely) value for TSH bioactivity [19] (not shown). In 
cells transfected with saturating amounts of the TSHR cDNA 
construct and incubated in isotonic (NaCl) (Fig. lA), higher 
basal CAMP levels were observed with respect to cells trans- 
fected with the vector alone, confirming the constitutive activity 
of the wt receptor described previously [%12,15] (Figs. lA, 2). 
Under the same conditions, cells transfected with the LHR 
construct displayed only minimal increase of CAMP levels 
(Figs. lA, 2). The TSHR caused at least a 5.5-fold CAMP 
increase (range 5.5520-fold in five experiments), whereas with 
the LHR the effect was always smaller than 1.Cfold (range 
I. 1-l .Cfold) (Figs. 1 A, 2). When cells were incubated in hypo- 
tonic (NaCll) buffer, basal CAMP production was higher in 
cells transfected with TSHR and, surprisingly, also in cells 
transfected with LHR (Fig. 2A). When incubated in isotonic 
(sucrose) buffer, cells transfected with TSHR displayed also 
higher levels of basal CAMP as compared with the same cells 
incubated in isotonic (NaCl) buffer. Similarly, cells expressing 
the LHR exibited a marked increase in basal CAMP production 
as compared with cells transfected with LHR and incubated in 
isotonic (NaCl) buffer (Figs. lB, 2B). Together, this suggests 
that removal of NaCl from the incubation medium increases 
the constitutive activity of the wt TSH receptor, while simulta- 
neously unmasking significant constitutive activity of the LH 
receptor. COS-7 cells transfected with the empty vector or with 
the DNA of the mouse melanocortin receptor (MCSR) used as 
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Fig. 1. Basal CAMP accumulation in COS-7 cells transfected with increasing amounts of the TSH or LH receptor DNA constructs. After incubation 
in isotonic (NaCl) buffer (panel A), or isotonic (sucrose) buffer (panel B) CAMP was measured as decribed in the method section. Note the different 
scales between the two panels. 
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Fig. 2. Basal CAMP accumulation in COS-7 cells transfected with 100 ng/dish of the LH, TSH or MC5 receptor constructs; the empty pSVL vector 
served as control. CAMP was measured 48 h after transfection following incubation in isotonic (NaCl), or hypotonic (NaCl-) buffers (panel A), and 
isotonic (NaCl) or isotonic (sucrose) buffers (panel B). Note the different scales between the two panels. Error bars are S.E.M. values of triplicates. 
controls showed the same basal CAMP accumulation in both 
isotonic buffers (Fig. 2B). 
The effect of varying the pH of the buffer (6.5-8) or the 
incubation temperature (2842°C) on the CAMP production 
was further investigated in cells expressing TSHR, LHR or 
MCSR, in isotonic (NaCl) buffer. These different conditions 
did not affect the constitutive activity of the TSHR and did not 
unmask significant constitutive basal activity of the LHR or 
MCSR (Fig. 3). 
(Fig. 4). MCSR retained high sensitivity to a-MSH (40 nM) in 
both conditions (Fig. 4). COS-7 cells transfected with the empty 
pSVL vector were not stimulated by any of the three agonists 
(Fig. 4). 
Agonist stimulated CAMP production was not affected when 
cells transfected with the three receptors were tested in isotonic 
(NaCl) buffer at different pH or temperatures of incubation 
(data not shown). 
4. Discussion 
3.2. Biological response to hTSH, hCG and a-MSH 
CAMP accumulation in response to stimulation by bTSH, Spontaneous mutations leading to the constitutive activation 
hCG and a-MSH was explored in cells transfected with TSHR, of G protein-coupled receptors have recently been implicated 
LHR and MCSR, respectively. Using isotonic (NaCl) buffer, in a series of hereditary and acquired diseases including toxic 
bTSH (10 mu/ml) and hCG (1 mu/ml) increased CAMP over thyroid hyperplasia [9,11,20] and hyperfunctioning thyroid ade- 
basal values by a factor of 12.3 (range 10-25) and 22.5 (range nomas (TSH receptor) [8,lO, 12,2 11, retinitis pigmentosa [22] 
1840) for TSHR and LHR, respectively (Fig. 4). When cells and night blindness (rhodopsin) [23], Jansen-Type metaphysial 
were assayed in isotonic (sucrose) buffer, in the same experi- dysplasia (PTH-PTHrP receptor) [24], autosomal dominant hy- 
ment, using the same concentration of agonists as above, the pocalcaemia (calcium sensor receptor) [25] and pseudo-preco- 
TSHR and LHR were both stimulated by a factor of 1.9 only cious puberty of the male (LH/CG receptor) [ 13,14,26,27]. Al- 
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Fig. 3. Effect of pH and temperature on basal CAMP accumulated in COS-7 cells expressing TSHR, LHR or MCSR; the empty pSVL vector served 
as control. Cells were incubated in isotonic (NaCl) buffer with differing pH (6.5-8) (panel A) or at different temperatures (2842°C) (panel B). Basal 
CAMP levels were measured as described in section 2. Note the different scales between the two panels. Error bars are S.E.M. values of triplicates. 
E Cetuni et al. IFEBS Letters 378 (1996) 27-31 30 
100 
80 
Z 
.e 60 
P 
Z 
fi 
; 40 
3 
20 
0 
pSVL TSHR LHR MCSR P5VL TSHR LHR MCSR 
Isotonic (NaCI) Isotonic (Sucrose) 
Fig. 4. Effect of NaCl on the response of COS-7 cells expressing the 
TSH, LH or MC5 receptors. COS-7 cells were transfected with saturat- 
ing concentrations of DNA (100 &dish) and intracellular CAMP levels 
w&-e determined under basal or agonist-stimulated conditions (bTSH 
IO mu/ml, hCG I mu/ml, a-MSH 40 nM) following incubation in two 
different media as indicated: isotonic (NaCI), (left); isotonic (sucrose) 
(right). Error bars are S.E.M. values of triplicates. 
though a series of different mutations have been demonstrated 
in each situation, the diversity of the gain-of-function muta- 
tions affecting the TSH receptor seems particularly high: muta- 
tions of thirteen different residues lead to receptor activation 
[S-12,20,28,29]. In agreement with a current model for G pro- 
tein-coupled receptor activation [30], this observation led us to 
propose that the unliganded TSH receptor would be less con- 
strained than others when in the inactive state [28 and MT 
submitted]. Giving support to this hypothesis, we and others 
had shown that the wt TSHR displayed significant constitutive 
activity, when transfected in COS-7 cells [g-12,1 5,16,20]. As the 
level of receptors achieved in COS-7 cells is several orders of 
magnitude higher than in thyrocytes, it remains to be demon- 
strated that constitutive activity of the wt TSH receptor has 
physiological relevance in vivo. Our present results demon- 
strate that, under identical experimental conditions, in a buffer 
containing physiological NaCl concentrations, neither the 
LHR nor the MCSR show significant constitutive activity to- 
wards adenylylcyclase. This confirms previous data obtained 
with the LHR [14,15,27] and suggests that LH and MC5 recep- 
tors are indeed subjected to a stronger silencing constraint that 
the TSHR. With the aim to explore whether the structure of 
TSHR would be more labile and, hence, more prone to autoac- 
tivation we subjected cells expressing the three receptors to 
incubation conditions which could destabilize the receptor 
structures. Whereas varying the pH or temperature was with- 
out effects, removal of NaCl from the medium (under hypo- 
tonic) (Fig. 2A) or isotonic conditions (Figs. IB. 2B) clearly 
enhanced the constitutive activity of the TSH receptor while 
simultaneously unmasking strong constitutive activity of the 
LHR. As the unliganded MC5 receptor remained silent under 
all conditions, this allows classification of the three receptors 
in three categories with increasing lability: MCSR, silent; LHR, 
silent under normal [NaCl], active in the absence of NaCl; 
TSHR, already constitutively active in normal [NaCl], further 
activated by removal of NaCI. These observations suggest that 
ionic interactions play a key role in the normal silencing of the 
unliganded LH receptor and in keeping at a relatively low level 
the constitutive activity of the TSH receptor. It is likely that the 
highly conserved aspartate residue present in the second trans- 
membrane segment of the vast majority of GPCRs (positions 
383 and 460 in the LH and TSH receptors, respectively) is 
implicated in this ionic interaction [31]. Substitution of this 
residue in LHR [31] as well as the corresponding residue in 
other members of GPCR [32-341, results in a decrease in affin- 
ity for agonists and abolishes the effect of [Na’] on affinity for 
agonists. 
Hidaka et al. [35,36], using COS-7 cells expressing TSHR or 
LHR failed to detect constitutive activity of the LHR in NaCI- 
free buffer containing sucrose. This study did not explore the 
behaviour of transfected cells incubated in a buffer containing 
physiological concentration of NaCl. The reason for the dis- 
crepancy with our results is unclear; a possible explanation 
being related to a lower efficiency of transfection in Hidaka et 
al. [35,36]. In our hands, the efficiency of transfection of COS-7 
cells ranges between 40 and 50% as measured by flow cyto- 
fluorimetry using a monoclonal antibody recognizing the ex- 
tracellular domain of the TSH receptor (S. Costagliola et al., 
to be published). In comparison with our observations, the 
constitutive activity observed for the TSHR by Hidaka et al. 
is much lower (2-fold increase of basal CAMP vs. 5-20-fold in 
our hands). 
A blunted CAMP response was observed after stimulation of 
the TSHR and LHR transfected cells with bTSH and hCG, 
respectively, when using isotonic (sucrose) buffer. This obser- 
vation suggests that the high basal activity displayed by both 
receptors under this condition, causes close to their full activa- 
tion. This characteristic has been previously observed for some 
of the activating mutations of the TSHR tested in normal 
[NaCl] [ 121. 
It has been recommended to incubate thyrocytes, FRTLS 
cells or transfected cell lines expressing the TSH receptor in low 
[NaCI] in order to increase the sensitivity of assays for thyroid 
stimulating auto-antibodies (TSAb) [37-391. In agreement with 
this practice, the affinity of the TSH receptor for binding of 
bovine TSH is higher in low [NaCl] [40]. One observation has 
been that by chasing low [NaCl] media for auto-antibody as- 
says, one improves detection of weak TSAbs, while decreasing 
the range of stimulation [37,38]. This is fully compatible with 
the present data. 
The number of receptors described, which are endowed with 
constitutive activity is increasing rapidly [4147]. The structural 
basis responsible for this phenomenon remains unknown. The 
observations in the present study open the way to the identifi- 
cation of the residues involved in the differential behaviour of 
the unliganded TSH and LH receptors. 
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